Description of impact
Case summaryThrough an Open Innovation Model to support research on antimicrobial resistance
(AMR) and difficult to treat infections, UKHSA offers its expertise and facilities to
researchers in order to work openly and collaboratively towards the goal of reducing
the infectious disease burden on public health. The Open Innovation in AMR model,
developed at UKHSA, supports innovation to discover and develop new
therapeutics, diagnostics and other types of intervention aimed at improving the
prevention and treatment of drug resistant infections. The work, supported by an
infrastructure grant from the Department of Health and Social Care (DHSC), has
enabled more than 60 collaborative studies over the last seven years and continues
to work with a number of partners in academia and industry, nationally and
internationally
| Category of impact | Health impacts, Social impacts |
|---|
Documents & Links
http://Fibrous matrices facilitate pleurocidin killing of wound associated bacterial pathogens
http://Tools to enable the study and translation of supramolecular amphiphiles
http://Synergy between Winter Flounder antimicrobial peptides
http://Adamantane appended antimicrobial supramolecular self-associating amphiphiles
http://Insights into the Spectrum of Activity and Mechanism of Action of MGB-BP-3
http://Synthetic Antimicrobial Peptide Tuning Permits Membrane Disruption and Interpeptide Synergy